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Background
Excessive inflammation after myocardial infarction (MI)
can be detrimental to the recovery of cardiac function.1,2
Ultrasmall superparamagnetic particles of iron oxide
(USPIO)-enhanced magnetic resonance imaging (MRI)
can be used to detect myocardial cellular inflammation.
USPIO are engulfed by resident macrophages through
phagocytosis and pinocytosis resulting in concentration
within inflamed tissues. We aimed to determine the time
course and duration of USPIO-enhancement following
acute MI (Figure 1).
Methods
Thirty patients with acute MI were studied in the 3-month
period following acute MI. Repeated T2*-weighted 3T
MRI was performed immediately before and 24 h after
USPIO (ferumoxytol, 4 mg/kg) administration at 2±1, 5±2,
13±3, 21±4 and 90±9 days. Myocardial regions of interest
(ROIs) were drawn and categorised into infarct and non-
infarct regions by the presence or absence of late gadoli-
nium enhancement (LGE). R2* values (1/T2*) within ROIs
were determined to assess the time course and duration of
uptake of USPIO.
Results
Following single-dose USPIO administration 2-7 days after
acute MI, USPIO uptake is demonstrable at 24 h (p<0.001)
and is cleared within 4-8 days. Increased USPIO uptake is
seen in the infarct region at days 2-3 (p<0.001), days 4-7
(p<0.01), and days 10-16 (p<0.05) compared to non-
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Figure 1 Patient imaged 5 days after an inferior MI. Images show late gadolinium enhancement in the region of the MI (left). R2* colour maps
of the baseline pre-USPIO scan (middle), and 24 hours following USPIO administration (right). USPIO uptake, with increased R2* values, is shown
by the lighter area of the colour map in the region of the inferior wall infarct (arrow).
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infarcted myocardium (Figure 2). There was no difference
in uptake between regions at later time points (21±4 and
90±9 days).
Conclusions
USPIO-enhanced MRI can detect and quantify infarct-
related cellular inflammation in the first 2 weeks following
acute MI. This imaging tool holds promise to non-inva-
sively assess myocardial cellular inflammation after MI
and in other inflammatory cardiac conditions. It has the
potential to monitor disease progression and remission,
and may provide a future platform on which to test novel
anti-inflammatory therapies for the heart.
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Figure 2 Increased USPIO uptake is seen in the infarct region at days 2-3 (p<0.001), 4-7 (p<0.01), and days 10-16 (p<0.05) compared to non-
infarcted myocardium. There is no difference in uptake at later time points (Days 81-99 not shown).
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